Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 8, 2002

View Archived Issues

Imatinib mesilate may modify the natural history of chronic myelogenous leukemia

SPI-77 is safe and more effective than carboplatin in dogs with osteosarcoma

Neuroprotective peptide humanin produced in vivo

Synergistic antitumor effect for irofulven combined with mitomycin D or thiotepa

Improved efficacy of calcipotriol plus betamethasone in psoriasis vulgaris

Imiquimod 5% cream reported to be highly effective against nongenital warts

Fujisawa and Sumitomo enter collaboration for oral carbapenem antibiotics

Flemington Pharmaceutical now known as NovaDel Pharma

CIMA to develop fast-dissolve version of Allegra

Key Oxcyte preclinical studies completed

SIGA and TransTech join forces to develop therapeutics for infectious diseases

Patient enrollment met in Preos POWER trial

Immune Network updates dapsone progress

Keryx extends manufacturing and negotiating rights for KRX-101

Pharmion launches Innohep

Activity of new pyrrolopyrimidine oxazolidinones against Gram-positive microorganisms

New Pharmacia oxazolidinone analogues compare favorably with linezolid

Multivalent aminoglycosides may be useful against aminoglycoside-resistant infections

New antibacterial beta-carboline compounds covered by GSK patent

NeoRx describes bone-selective metal complexes for diagnostic and therapeutic applications

Novel NK1 antagonists and their use in depression and emesis

GSK develops new series of 5-HT7 antagonists

Roche researchers identify new HDAC inhibitors

Novel GSK-3beta inhibitors prepared and tested at Mitsubishi Pharma

Preferential dopamine D3 antagonist with promising preclinical antipsychotic profile

Karo Bio presents thyroid receptor antagonists with potential in arrhythmia and other disorders

E-6006 citrate effective in rat model of obsessive-compulsive disorder

GSK 5-HT1B receptor antagonist effective in animal models of depression and anxiety

Remodulin approved in Canada

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026